Albemarle to increase production capacity in Pasadena

Albemarle Corporation (NYSE: ALB), a global developer, manufacturer and marketer of highly engineered specialty chemicals and services, announced today that it plans to increase production capabilities of its curatives products at its facility in Pasadena, Texas. The capacity investment will support Albemarle's ETHACURE® 100 liquid curative product for application in polyureas, urethanes and epoxies.

Albemarle's ETHACURE 100 curatives are effective curing agents and chain extenders for polyurethane and polyurea elastomers, as well as epoxy resins, particularly in reaction injection molding and spray applications. These diamine curatives allow for adjustable reaction time and substantially reduce dust exposure while providing processing advantages and improved final product properties.

"We are excited to announce our plans for increased production at a robust production site," said Chris Knight, Albemarle's vice president, Specialty Chemicals. "This expansion will allow Albemarle to meet the needs of our customers by continuing to provide high quality products and customer service and will strengthen our position as a leading supplier in the curatives industry."

Production in the expanded facility is expected in 2015.

Source: Albemarle